CFTR and cystic fibrosis: Specifically, Fenretide increases IL-1β expression in Cftr-knockout mice, improving their ability to combat P. aeruginosa lung infection [52]; in addition, it normalizes the fatty acid imbalance by reducing arachidonic acid and increasing docosahexaenoic acid in CF patients [53].